About Regenerative Medical Solutions
Regenerative Medical Solutions is a company based in Madison, United States. The News Front has published 3 press releases from Regenerative Medical Solutions, most recently on 1 October 2025.
Regenerative Medical Solutions (RMS), a Chicago and Madison-based company, was formed to combat these alarming trends in diabetes through the use of its stem cell derived Islet-Like Clusters (ILC) for dual use in drug discovery applications (screening, toxicity, efficacy testing) and direct therapeutic use targeting diabetes.
Latest news
Latest release1 October 2025
Wisconsin Biotech Company Secures NIH Grant to Revolutionize Diabetes Treatment
MADISON, WISCONSIN – Regenerative Medical Solutions (RMS), a Wisconsin-based biotech company, has been awarded a peer-reviewed National Institutes of Health (NIH) Phase II Small Business Innovation Research (SBIR) grant of approximately $1.8 million to advance its prospective cure for diabetes to the next stage of trials. RMS is inviting visionary investors to join its mission of…
Read the full release →29 Jul 2025
RMS Announces 25% Wisconsin Tax Credit for Investing in Prospective Cure for Diabetes
Madison, Wisconsin – The Wisconsin Economic Development Corporation (WEDC) has approved a 25% tax credit for investors in a groundbreaking diabetes cure…
29 Oct 2024
RMS Sponsors the 5th Summit on Stem Cell Derived Islets
Boston, MA – Regenerative Medical Solutions (RMS) is sponsoring the 5th Summit on Stem Cell Derived Islets, which will be held on October…